Your browser doesn't support javascript.
Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory.
Chamberlain, Alanna M; Cooper-DeHoff, Rhonda M; Fontil, Valy; Nilles, Ester Kim; Shaw, Kathryn M; Smith, Myra; Lin, Feng; Vittinghoff, Eric; Maeztu, Carlos; Todd, Jonathan V; Carton, Thomas; O'Brien, Emily C; Faulkner Modrow, Madelaine; Wozniak, Gregory; Rakotz, Michael; Sanchez, Eduardo; Smith, Steven M; Polonsky, Tamar S; Ahmad, Faraz S; Liu, Mei; McClay, James C; VanWormer, Jeffrey J; Taylor, Bradley W; Chrischilles, Elizabeth A; Wu, Shenghui; Viera, Anthony J; Ford, Daniel E; Hwang, Wenke; Knowlton, Kirk U; Pletcher, Mark J.
  • Chamberlain AM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN. Electronic address: chamberlain.alanna@mayo.edu.
  • Cooper-DeHoff RM; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville; Division of Cardiovascular Medicine, College of Medicine, University of Florida, Gainesville.
  • Fontil V; Division of General Internal Medicine, Department of Medicine, University of California San Francisco; UCSF Center for Vulnerable Populations, San Francisco General Hospital, San Francisco, CA.
  • Nilles EK; Duke Clinical Research Institute, Duke University, Durham, NC.
  • Shaw KM; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville.
  • Smith M; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville.
  • Lin F; Department of Epidemiology and Biostatistics, University of California San Francisco.
  • Vittinghoff E; Department of Epidemiology and Biostatistics, University of California San Francisco.
  • Maeztu C; Citizen Scientist, Department of Health Outcomes and Biomedical Informatics, University of Florida, Gainesville.
  • Todd JV; OCHIN Inc, Portland, OR.
  • Carton T; Louisiana Public Health Institute, New Orleans.
  • O'Brien EC; Duke Clinical Research Institute, Duke University, Durham, NC.
  • Faulkner Modrow M; Department of Epidemiology and Biostatistics, University of California San Francisco.
  • Wozniak G; American Medical Association, Chicago, IL.
  • Rakotz M; American Medical Association, Chicago, IL.
  • Sanchez E; American Heart Association, Dallas, TX.
  • Smith SM; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville.
  • Polonsky TS; Department of Medicine, University of Chicago Medicine, Chicago, IL.
  • Ahmad FS; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Liu M; Division of Medical Informatics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City.
  • McClay JC; Department of Emergency Medicine, University of Nebraska Medical Center, Omaha.
  • VanWormer JJ; Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Marshfield, WI.
  • Taylor BW; Medical College of Wisconsin, Milwaukee.
  • Chrischilles EA; Department of Epidemiology, University of Iowa, Iowa City.
  • Wu S; Department of Health and Exercise Science, Appalachian State University, Boone, NC.
  • Viera AJ; Department of Family Medicine and Community Health, Duke University, Durham, NC.
  • Ford DE; Johns Hopkins Institute for Clinical and Translational Research, Baltimore, MD.
  • Hwang W; Penn State University College of Medicine, Hershey, PA.
  • Knowlton KU; Cardiovascular Department, Intermountain Heart Institute, Salt Lake City, UT.
  • Pletcher MJ; Department of Epidemiology and Biostatistics, University of California San Francisco.
Mayo Clin Proc ; 98(5): 662-675, 2023 05.
Article in English | MEDLINE | ID: covidwho-2211123
ABSTRACT

OBJECTIVE:

To explore trends in blood pressure (BP) control before and during the COVID-19 pandemic. PATIENTS AND

METHODS:

Health systems participating in the National Patient-Centered Clinical Research Network (PCORnet) Blood Pressure Control Laboratory Surveillance System responded to data queries, producing 9 BP control metrics. Averages of the BP control metrics (weighted by numbers of observations in each health system) were calculated and compared between two 1-year measurement periods (January 1, 2019, through December 31, 2019, and January 1, 2020, through December 31, 2020).

RESULTS:

Among 1,770,547 hypertensive persons in 2019, BP control to <140/<90 mm Hg varied across 24 health systems (range, 46%-74%). Reduced BP control occurred in most health systems with onset of the COVID-19 pandemic; the weighted average BP control was 60.5% in 2019 and 53.3% in 2020. Reductions were also evident for BP control to <130/<80 mm Hg (29.9% in 2019 and 25.4% in 2020) and improvement in BP (reduction of 10 mm Hg in systolic BP or achievement of systolic BP <140 mm Hg; 29.7% in 2019 and 23.8% in 2020). Two BP control process metrics exhibited pandemic-associated disruption repeat visit in 4 weeks after a visit with uncontrolled hypertension (36.7% in 2019 and 31.7% in 2020) and prescription of fixed-dose combination medications among those with 2 or more drug classes (24.6% in 2019 and 21.5% in 2020).

CONCLUSION:

BP control decreased substantially during the COVID-19 pandemic, with a corresponding reduction in follow-up health care visits among persons with uncontrolled hypertension. It is unclear whether the observed decline in BP control during the pandemic will contribute to future cardiovascular events.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hypertension Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Mayo Clin Proc Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hypertension Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Mayo Clin Proc Year: 2023 Document Type: Article